O que significa “Limpar”?
O animal não carrega a mutação. Não desenvolverá a doença e não vai passar adiante.
Cachorro Doença de armazenamento de glicogênio II em Lapphunds (GDSII)
Glycogen Storage Disease II (GSDII) in Lapphunds is a rare genetic disorder affecting muscle function and energy metabolism. Early DNA testing for GSDII helps identify carriers and affected dogs, enabling responsible breeding decisions. This test is crucial for Lapphund owners and breeders to prevent the spread of this debilitating condition. By using a reliable DNA test for GSDII, you can ensure the health and longevity of your Lapphund. Regular screening supports early diagnosis and better management of symptoms. Protect your Lapphund’s future with accurate genetic testing for Glycogen Storage Disease II today. Stay informed and promote healthier generations of Lapphunds through DNA testing.
Abreviatura: GDSII
Mutação analisada: GAA c.2237G>A
Herança: Autossômico Recessivo
Acrônimo
GDSII
Frequência observada
Gravidade clínica
Classificação clínica
Doenças Metabólicas
Mutação analisada
GAA c.2237G>A
Modo de herança
Autossômico Recessivo
Resumo do teste:
Glycogen Storage Disease II (GSDII) in Lapphunds is a genetic disorder affecting the breakdown of glycogen in muscle cells. This condition leads to muscle weakness, respiratory difficulties, and reduced mobility in affected dogs. A DNA test can identify carriers and affected individuals, helping breeders make informed decisions. Early diagnosis through genetic screening is crucial for managing the disease and improving the dog's quality of life. Responsible breeding practices can reduce the incidence of GSDII in the Lapphund population.
Disponível no pacote: Basic
Este teste de DNA está incluído a partir do nosso pacote Basic - e também faz parte dos packs Basic, Standard, Advanced, Complete.
Ver pacotes de teste de DNA →Escolha o pack que melhor se adapta à sua estratégia de criação ou saúde dos seus animais.
Understanding Glycogen Storage Disease II (GSDII)
Glycogen Storage Disease II (GSDII), also known as Pompe disease, is a genetic disorder that affects the metabolism of glycogen in certain dog breeds, including Lapphunds. This condition is caused by a deficiency in the enzyme acid alpha-glucosidase, which is crucial for breaking down glycogen into glucose, the primary energy source for cells. When this enzyme is deficient or absent, glycogen accumulates in the body's tissues, leading to various health complications.
Symptoms of GSDII
The symptoms of Glycogen Storage Disease II can vary widely among affected dogs, but common signs include muscle weakness, exercise intolerance, and respiratory distress. Puppies may exhibit difficulty in gaining weight and may have a poor growth rate. In more severe cases, the disease can lead to progressive muscle degeneration, resulting in decreased mobility and potential heart issues. Early identification of these symptoms is important for managing the condition effectively.
Diagnosis of GSDII
Diagnosis of Glycogen Storage Disease II typically involves clinical evaluation and genetic testing. A veterinarian may suspect GSDII based on the dog’s symptoms and family history. The definitive diagnosis is often confirmed through a DNA test that identifies mutations in the GAA gene, which encodes the acid alpha-glucosidase enzyme. Genetic testing allows for the identification of carriers and affected individuals, aiding in responsible breeding practices.
Opções de manejo e tratamento
While there is currently no cure for Glycogen Storage Disease II, management strategies focus on improving the quality of life for affected dogs. Supportive care may include physical therapy to maintain muscle strength and mobility, as well as dietary management to help optimize energy levels. In some cases, enzyme replacement therapy is being explored as a potential treatment option, although it may not be widely available for dogs as it is for humans.
Importance of Genetic Testing
Genetic testing for Glycogen Storage Disease II plays a crucial role in breed health management. By identifying carriers and affected dogs, breeders can make informed decisions to reduce the prevalence of this condition in future generations. Responsible breeding practices, including genetic screening, can help minimize the risk of GSDII and promote the overall health and well-being of Lapphunds.
Raça reconhecida para o teste: Doença de armazenamento de glicogênio II em Lapphunds (GDSII)
- Finnish Lapphund
- Lapphund
🧬 Interpretation of genotypes GDSII
Genótipo
Status
🟡 N/N
Não portador - sem risco
🟡 N/GDSII
Transportadora - Sem Risco
❌ GDSII/GDSII
Afetados - Em risco
FAQ: entendendo a interpretação
Um “transportador” é sério?
Não. O animal é geralmente saudável, mas pode transmitir a mutação ao seu descendência.
E se um animal for “afetado”?
Ele carrega duas cópias mutadas. Os sinais clínicos são esperados dependendo a doença. Não deveria ser criado.
Por que existem diferenças entre homem/mulher?
Algumas doenças estão ligadas ao sexo, pelo que a sua expressão varia dependendo do sexo do animal.
Prever descendência
N/N (nao-portador)
N/GDSII (Operadora)
GDSII/GDSII (Afetado)
Perguntas frequentes sobre testes de DNA
O que este teste de DNA detecta?
This DNA test detects the mutation associated with Glycogen Storage Disease II In Lapphunds (GSDII) in order to identify clear, carrier, or at-risk animals.
Por que testar um animal reprodutor?
Os testes de DNA ajudam os criadores a planejar acasalamentos mais seguros e a reduzir o risco de transmissão da mutação aos descendentes.
Qual é o modo de herança deste teste?
O modo de herança relatado para este teste é Autossômico Recessivo.
Qual mutação é analisada neste teste?
This test analyses the mutation GAA c.2237G>A.
Um animal portador é necessariamente afetado?
Não necessariamente. A interpretação depende do padrão de herança e do genótipo resultante.
Referências
Seppälä Eija H, Reuser Arnold J J, Lohi Hannes. A nonsense mutation in the acid α-glucosidase gene causes Pompe disease in Finnish and Swedish Lapphunds. PLoS One. 2013;8(2):e56825. doi: 10.1371/journal.pone.0056825. Epub 2013 Feb 14.